{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:20Z","timestamp":1774485500974,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["U54 AI057156"],"award-info":[{"award-number":["U54 AI057156"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH R21","award":["AI077077"],"award-info":[{"award-number":["AI077077"]}]},{"name":"James W. McLaughlin fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.058","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:54:25Z","timestamp":1311900865000},"page":"7444-7455","source":"Crossref","is-referenced-by-count":21,"title":["Enhancing the utility of a prM\/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene"],"prefix":"10.1016","volume":"29","author":[{"given":"Tomohiro","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas G.","family":"Widman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Infante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandro R.","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.058_bib0005","series-title":"Fields virology","article-title":"Flaviviruses","author":"Gubler","year":"2007"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0010","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1708-8305.2007.00134.x","article-title":"Japanese encephalitis for a reference to international travelers","volume":"14","author":"Oya","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.1996.tb124960.x","article-title":"An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995","volume":"165","author":"Hanna","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0025","series-title":"Vaccines","article-title":"Japanese Encephalitis vaccines","author":"Halstead","year":"2008"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0030","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1016\/j.vaccine.2007.05.034","article-title":"WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1\u20132 June 2006","volume":"25","author":"Ferguson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1101\/gad.1793309","article-title":"The role of RNAi and microRNAs in animal virus replication and antiviral immunity","volume":"23","author":"Umbach","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11908-008-0050-7","article-title":"Acute disseminated encephalomyelitis","volume":"10","author":"Sejvar","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1586\/erv.09.112","article-title":"Ixiaro: a new vaccine against Japanese encephalitis","volume":"8","author":"Jelinek","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0050","first-page":"CD004263","article-title":"Vaccines for preventing Japanese encephalitis","volume":"18","author":"Schioler","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0060","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/JVI.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(08)60263-8","article-title":"Epitope mapping of flavivirus glycoproteins","volume":"31","author":"Heinz","year":"1986","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0075","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","article-title":"Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine","volume":"77","author":"Kojima","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0085","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0090","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00346-9","article-title":"A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen","volume":"97","author":"Hunt","year":"2001","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JVI.72.1.191-200.1998","article-title":"DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice","volume":"72","author":"Lin","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2005.03.026","article-title":"A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model","volume":"112","author":"Volpina","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0110","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vaccine.2005.07.059","article-title":"Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence","volume":"24","author":"Costa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JVI.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0125","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1128\/JVI.01850-08","article-title":"Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells","volume":"83","author":"Krishna","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.virol.2006.04.003","article-title":"Production and characterization of vaccines based on flaviviruses defective in replication","volume":"351","author":"Mason","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0140","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2008.03.009","article-title":"Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system","volume":"26","author":"Widman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt1400","article-title":"Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus","volume":"26","author":"Chang","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0150","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1016\/j.vaccine.2009.07.016","article-title":"a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters","volume":"27","author":"Widman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0155","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4269\/ajtmh.2010.09-0310","article-title":"Evaluation of RepliVAX WN, a single-cycle Flavivirus vaccine, in a non-human primate model of West Nile Virus infection","volume":"82","author":"Widman","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0160","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2008.03.010","article-title":"Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis","volume":"26","author":"Ishikawa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0165","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JVI.01891-08","article-title":"Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2","volume":"83","author":"Suzuki","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0170","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","article-title":"Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies","volume":"141","author":"Kimura-Kuroda","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0175","doi-asserted-by":"crossref","first-page":"11148","DOI":"10.1128\/JVI.00446-07","article-title":"West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR","volume":"81","author":"Gilfoy","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0180","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1128\/JVI.00316-07","article-title":"Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production","volume":"81","author":"Bourne","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0185","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1093\/nar\/16.15.7351","article-title":"A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions","volume":"16","author":"Higuchi","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0195","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0200","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0205","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0210","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/S0264-410X(03)00488-2","article-title":"Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys","volume":"21","author":"Whitehead","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0215","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JVI.74.7.3020-3028.2000","article-title":"Chimeric dengue type 2 (vaccine strain PDK-53)\/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine","volume":"74","author":"Huang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1099\/0022-1317-71-3-745","article-title":"Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus","volume":"71","author":"Tan","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0225","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1099\/0022-1317-69-8-2101","article-title":"Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus","volume":"69","author":"Henchal","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0230","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0042-6822(92)91233-K","article-title":"A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine","volume":"190","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2009.12.023","article-title":"Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination","volume":"129","author":"Gao","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/viro.1999.9956","article-title":"Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1","volume":"264","author":"Hall","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0245","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1128\/JVI.71.12.9608-9617.1997","article-title":"Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication","volume":"71","author":"Lindenbach","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0250","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1128\/JVI.73.6.4611-4621.1999","article-title":"Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function","volume":"73","author":"Lindenbach","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0255","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1128\/JVI.69.11.7232-7243.1995","article-title":"Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum","volume":"69","author":"Falgout","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0260","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0265","series-title":"Fields virology","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/viro.1998.9156","article-title":"Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A","volume":"245","author":"Mackenzie","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0275","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1099\/vir.0.012864-0","article-title":"NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus","volume":"90","author":"Shiryaev","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0280","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0264-410X(00)00191-2","article-title":"Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans","volume":"19","author":"Kanesa-thasan","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0285","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0290","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0295","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1016\/S0264-410X(03)00507-3","article-title":"Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice","volume":"21","author":"Takasaki","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0300","first-page":"277","article-title":"Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques","volume":"36","author":"Goverdhan","year":"1992","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0305","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","article-title":"Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2011.07.058_bib0315","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T12:44:38Z","timestamp":1686228278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":63,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11011030"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}